Navigation Links
New guidance on making work less of a pain in the back
Date:5/1/2009

New guidance for employers, patients and doctors on helping people with back pain return to work will be announced on Tuesday May 5 at the University of Leicester.

It is estimated that it costs society in excess of 12 billion a year with people taking time off work because of back pain. Around 80% of these costs, were not associated with healthcare but due to lost work production and associated wage replacement benefits.

"These figures demonstrate the importance of maintaining people with chronic pain in useful employment," says Professor Paul Watson of the University of Leicester Department of Health Sciences who was among a group of researchers investigating back pain and its impact in the workplace.

"The role of healthcare practitioners in sanctioning work absence has been investigated and this has demonstrated that the health service is currently ill equipped to manage work loss in people with chronic pain and may in itself contribute to the high societal costs."

The reasons why people become disabled by chronic pain are not entirely explained by the severity of pain or the pathology but are better explained by the interaction of complex psychological and societal factors. Treatments which ignore these factors risk perpetuating the problem of chronic disability and work loss.

Professor Watson will present his report at the University of Leicester on Tuesday 5 May at 5.30pm. The lecture takes place in the Ken Edwards Building, Lecture Theatre 1 and is open to the public and free.

Key recommendations are:

  • Assessment of the key, psychosocial barriers to successful rehabilitation
  • Development of an action plan to provide comprehensive treatment to address these barriers.
  • A co-ordinated approach involving of healthcare workers, employers and patients to prevent work loss
  • A recognition that a return to full engagement in society, including work, is beneficial to health of those with chronic pain.

Following the lecture, an evidence based guide for clinicians, patients and employers on how to help people with chronic pain remain in work will be published. This was funded by a group including clinical interest groups, employers and health insurance companies. It will be made available as a free PDF.

Professor Watson said: "This work is extremely topical. The Chief Medical Officer has just released a report identifying the need to improve the management of pain. Dame Carol Black has launched an initiative to try and return people with chronic health problems to work - much of what she recommends is included in our evidence based review and underpins our previous research in this area over the last six years.

"The University of Leicester has been instrumental in performing key research on returning unemployed people with chronic pain to work and we have written a number of reports on the barriers and bridges to employment in this group.

"We are currently conducting research in how healthcare services can be made more effective in assisting people to remain in work by educating GPs on returning people with back pain to work - the results of this work will not be out until next year."


'/>"/>

Contact: University of Leicester Press Office
pressoffice@le.ac.uk
University of Leicester
Source:Eurekalert

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
3. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
4. West Pharmaceutical Services Updates Annual Guidance
5. Medifast Announces Updated Full Year 2007 Guidance
6. Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
7. Bradmer provides Phase III Neuradiab trial update and guidance
8. QLT announces Visudyne(R) sales for third quarter and provides Visudyne sales guidance for 2007
9. Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
10. Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track
11. Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their pencils ... an essay contest in which patients and their families pay tribute to a genetic ... 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) sponsors ... on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, ... to helping service members that have been wounded in battle and their families. Venture ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
Breaking Medicine Technology: